Quince Therapeutics, Inc. (QNCX)

Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.21	20.75	44.58	69.72	66.84
Short-Term Investments	34.57	54.31	45.6	37.08	66.98
Cash & Short-Term Investments	40.78	75.06	90.18	106.8	133.82
Cash Growth	-45.66%	-16.77%	-15.56%	-20.19%	34.00%
Other Receivables	0.88	0.99	1	1.13	-
Receivables	0.88	0.99	1	1.13	-
Prepaid Expenses	0.99	1.17	1.2	1.48	1.24
Other Current Assets	1.38	0.21	1.36	2.27	2.8
Total Current Assets	44.04	77.44	93.75	111.67	137.86
Property, Plant & Equipment	0.81	0.62	0.68	1.43	1.1
Long-Term Investments	0.08	0.08	3.58	19.93	50.46
Goodwill	-	17.63	-	-	-
Other Intangible Assets	60.05	63.67	5.9	-	-
Other Long-Term Assets	9.51	8.47	-	0.19	0.04
Total Assets	114.48	167.9	103.91	133.23	189.47
Accounts Payable	2.9	2.03	0.57	4.91	3.56
Accrued Expenses	3.97	3.12	1.86	8.39	13.16
Current Portion of Leases	0.1	0.06	0.45	0.74	0.24
Other Current Liabilities	0.31	4.36	0.19	0.18	0.04
Total Current Liabilities	7.28	9.57	3.07	14.22	17
Long-Term Debt	14.32	13.43	-	-	-
Long-Term Leases	0.39	0.32	-	0.42	0.21
Long-Term Deferred Tax Liabilities	4.96	5.3	0.25	-	-
Other Long-Term Liabilities	57.38	54.19	-	-	-
Total Liabilities	84.33	82.82	3.32	14.64	17.2
Common Stock	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	406.61	401.64	389.11	355.23	318.57
Retained Earnings	-376.47	-319.64	-288.26	-236.6	-146.65
Comprehensive Income & Other	-0.04	3.05	-0.29	-0.08	0.31
Total Common Equity	30.15	85.08	100.59	118.59	172.26
Shareholders' Equity	30.15	85.08	100.59	118.59	172.26
Total Liabilities & Equity	114.48	167.9	103.91	133.23	189.47
Total Debt	14.81	13.81	0.45	1.16	0.45
Net Cash (Debt)	25.97	61.25	89.73	105.64	133.37
Net Cash Growth	-57.59%	-31.74%	-15.06%	-20.79%	33.56%
Net Cash Per Share	0.60	1.64	2.68	3.55	4.57
Filing Date Shares Outstanding	44	43.22	36.28	30.15	29.55
Total Common Shares Outstanding	44	42.97	36.14	30.07	29.54
Working Capital	36.76	67.87	90.68	97.45	120.87
Book Value Per Share	0.69	1.98	2.78	3.94	5.83
Tangible Book Value	-29.9	3.79	94.69	118.59	172.26
Tangible Book Value Per Share	-0.68	0.09	2.62	3.94	5.83
Machinery	0.89	0.68	0.43	0.61	0.46
Leasehold Improvements	0.03	0.04	0.02	0.06	0.02

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q